Lind Kevin Robert bought AVTX
September 30, 2026 · Form 4 insider transaction
Lind Kevin Robert bought 1,352 shares of Avalo Therapeutics, Inc. at $12.29 per share, a transaction worth $16.6K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,352
Price
$12.29
Total value
$16.6K
InsiderLind Kevin Robert
RoleOfficer, Director
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateSeptember 30, 2026
Filing dateOctober 2, 2026
Shares owned after1,352
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The options were issued to the Reporting Person pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Plan in lieu of Board fees.; The options were granted on September 30, 2026, and are 100% vested.